George Llado

Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA.

TraceLink, Inc. provides pharmaceutical serialization, drug track, trace compliance, and supply network performance solutions. It offers SupplyNexus that enables to create a collaborative supply community; ServiceLink, a collaboration platform to centrally monitor and manage track and trace. The company was founded by Peter Monahan, Graham Clark, Shabbir Mansur Dahod, Peter J. Spellman, Luciana Deus, John Kordash and Brian Daleiden in 2009 and is headquartered in North Reading, MA.